Abstract
Celiac disease (CD) is not commonly associated with obesity; however, many patients are overweight or obese at time of diagnosis. As the number of people in the United States with obesity continues to rise, it is not known if the prevalence of obesity among patients with CD has also increased. This study utilized an electronic health record database incorporating over 360 individual hospitals in the United States (Explorys Incorporated, Cleveland, OH). Adult patients who had an esophagogastroduodenoscopy at least 1 day prior to reporting of CD from the years 2014 to 2018 formed the study population. From 2014 to 2018, 13,410 patients had a diagnosis of CD. The prevalence of obesity was 45,000/100,000 persons in this CD population. Prevalence of class I (BMI 30–34.9), II (BMI 35–39.9), and III (BMI > 40) obesity in patients with CD continued to rise over the 5-year span. Class I obesity had the highest prevalence and Class II the highest prevalence increase when obesity classes were compared. Clinicians should be aware of obesity as a comorbidity of increasing prevalence when providing longitudinal care for patients with CD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Semeraro LA, Barwick KW, Gryboski JD. Obesity in celiac sprue. J Clin Gastroenterol. 1986;8:177–80.
Venkatasubramani N, Telega G, Werlin SL. Obesity in pediatric celiac disease. J Pediatr Gastroenterol Nutr. 2010;51:295–7.
Van der Pals M, Myléus A, Norström F, Hammarroth S, Högberg L, Rosén A, et al. Body mass index is not a reliable tool in predicting celiac disease in children. BMC Pediatr. 2014;14:165–71.
Cheng J, Brar PS, Lee AR, Green PHR. Body mass index in celiac disease. J Clin Gastroenterol. 2010;44:267–71.
Stein AC, Liao C, Paski S, Polonsky T, Semrad CE, Kupfer SS. Obesity and cardiovascular risk in adults with celiac disease. J Clin Gastroenterol. 2016;50:545–50.
Kabbani TA, Goldberg A, Kelly CP, Pallav K, Tariq S, Peer A, et al. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther. 2012;35:723–9.
Tucker E, Rostami K, Prabhakaran S, Al, Dulaimi D. Patients with coeliac disease are increasingly overweight or obese on presentation. J Gastrointestin Liver Dis. 2012;21:11–15.
Tortora R, Capone P, De Stefano G, Imperatore N, Gerbino N, Donetto S, et al. Metabolic syndrome in patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2015;41:352–9.
IBM Explorys EHR Solutions. Data Sheet - IBM Explorys Electronic Health Record (EHR) Database. Somers, NY: IBM Corporation; 2019. https://www.ibm.com/downloads/cas/6VQK0DLL.
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–77.
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–44.
Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. J Am Med Assoc. 2018;319:1723–5.
Therrien A, Kelly CP, Silvester JA. Celiac disease: extraintestinal manifestations and associated conditions. J Clin Gastroenterol. 2020;54:8–21.
Rubio-Tapia A, Rahim W, See JA, Lahr BD, Wu T-T, Murray JA. MucosaL Recovery and Mortality in Adults with Celiac Disease after Treatment with A Gluten-free Diet. Am J Gastroenterol. 2010;105:1412–20.
Mahadev S, Murray JA, Wu T-T, Chandan VS, Torbenson MS, Kelly CP, et al. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther. 2017;45:1084–93.
Parzanese I, Qehajaj D, Patrinicola F, Merica A, Chiriva-Internati M, Stifler S, et al. Celiac disease: from pathophysiology to treatment. World J Gastrointest Pathophysiol. 2017;8:27–38.
El Khoury D, Balfour-Ducharme S, Joye IJ. A review on the gluten-free diet: technological and nutritional challenges. Nutrients. 2018;10:1410–35.
Wild D, Robins GG, Burley VJ, Howdle PD. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther. 2010;32:573–81.
Babio N, Alcázar M, Castillejo G, Recasens M, Martínez-Cerezo F, Gutiérrez-Pensado V, et al. Patients with celiac disease reported higher consumption of added sugar and total fat than healthy individuals. J Pediatr Gastroenterol Nutr. 2017;64:63–69.
Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions—but do we have the will? Fertil Steril. 2017;107:833–9.
Author information
Authors and Affiliations
Contributions
AD—visualization, writing-original draft preparation, writing-review and editing. SS—formal analysis, investigation, writing-original draft preparation, writing-review and editing. MI—data curation, formal analysis, investigation, visualization, writing-original draft preparation. RS—conceptualization, formal analysis, investigation, visualization, writing-original draft preparation. GC—supervision, writing-original draft preparation.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Drosdak, A., Satyavada, S., Ismail, M. et al. Obesity prevalence in celiac disease in the United States from 2014 to 2018. Int J Obes 46, 441–443 (2022). https://doi.org/10.1038/s41366-021-01008-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-021-01008-9